Litcius/Paper detail

Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment

William W. Busse, Eugene R. Bleecker, J. Mark FitzGerald, Gary T. Ferguson, Peter Barker, Laura Brooks, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman

2021Journal of Allergy and Clinical Immunology38 citationsDOI

Topics & Concepts

BenralizumabPlaceboMedicineExacerbationAdverse effectAsthma exacerbationsAsthmaDiscontinuationInternal medicineEosinophilMepolizumabPathologyAlternative medicineAsthma and respiratory diseasesChronic Obstructive Pulmonary Disease (COPD) ResearchDelphi Technique in Research
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment | Litcius